Pharmacist‐led medication review in a residential in‐reach service leads to deprescribing
Australasian Journal on Ageing · 2023
DOI: 10.1111/ajag.13215 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Australasian Journal on Ageing, 2023. Verfasst von Jia Hao Hui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Home, Acute and Community, Alfred Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Deprescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objective
To examine the effect of a pharmacist‐led medication review on deprescribing medications in a Residential In‐Reach (RIR) service which provides acute care substitution to residential aged care residents.
Methods
A pre‐post observational study was conducted. Patient characteristics and admission and discharge medications were collected over two 3‐month phases before (prephase) and after (postphase) the introduction of a pharmacist who performed a comprehensive medication review and provided deprescribing recommendations. The Screening Tool of Older Persons' Prescriptions (STOPP) version 2 was used to identify potentially inappropriate medications (PIMs). The Drug Burden Index (DBI) was used to measure cumulative anticholinergic and sedative medication burden. Outcome of deprescribing was measured by the reduction in the number of PIMs, DBI scores and proportion of polypharmacy from admission to discharge.
Results
The prephase included 59 patients (mean age 87.3 years, 63% female), and the postphase included 88 patients (mean age 87.3 years, 63% female). There was a significant reduction in the mean number of PIMs (pre +0.05 ± 2.59 vs. post −0.78 ± 2.32, p = 0.04) and median DBI (pre −0.004 ± 0.17 vs. post −0.07 ± 0.2, p = 0.03) in postphase compared to prephase. The proportion of polypharmacy at discharge was reduced in the postphase (pre‐100% vs. post‐90%, p = 0.01). The most deprescribed PIMs as measured by STOPP in postphase were drugs without indication, cardiovascular system drugs and gastrointestinal system drugs.
Conclusions
The introduction of a pharmacist‐led medication review in RIR service was associated with a significant reduction in the mean number of PIMs, median DBI and polypharmacy. Future studies are needed to determine whether deprescription is sustained to examine correlations to long‐term patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Home, Acute and Community, Alfred Health, Melbourne, Victoria, Australia.
- Central Clinical School, Monash University, Melbourne, Victoria, Australia.
- Departments of Clinical Pharmacology and Ageing, Kolling Institute, Royal North Shore Hospital, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
- Department of Pharmacy, Alfred Health, Melbourne, Victoria, Australia.
ORCID-Profile: Jia Hao Hui, Amelia Crabtree
Zitieren
APA
Hui, J. H., Parikh, S., Kouladjian O'Donnell, L., Mcinerney, B., Dillon, L., Poojary, S., & Crabtree, A. (2023). Pharmacist‐led medication review in a residential in‐reach service leads to deprescribing. Australasian Journal on Ageing. https://doi.org/10.1111/ajag.13215
Vancouver
Hui JH, Parikh S, Kouladjian O'Donnell L, Mcinerney B, Dillon L, Poojary S, et al. Pharmacist‐led medication review in a residential in‐reach service leads to deprescribing. Australasian Journal on Ageing. 2023. doi:10.1111/ajag.13215
BibTeX
@article{Hui2023,
author = {Hui, Jia Hao and Parikh, Seema and Kouladjian O'Donnell, Lisa and Mcinerney, Brigid and Dillon, Louise and Poojary, Suma and Crabtree, Amelia},
title = {Pharmacist‐led medication review in a residential in‐reach service leads to deprescribing},
journal = {Australasian Journal on Ageing},
year = {2023},
doi = {10.1111/ajag.13215}
}
EUVIMED